Furthermore, compared to COVID-19 individuals, LTBI/COVID-19 individuals showed an increased degranulation capacity of CD8+ T cells, along with similar frequencies of CD8+perforin+ and CD8+Granzime+ T cells, and reduced levels of soluble cytotoxic molecules regardless of the stimuli. This evidence concerns the gene PRF1 and COVID-19.